CLDX
Price
$33.51
Change
-$4.38 (-11.56%)
Updated
Sep 22 closing price
Capitalization
3B
49 days until earnings call
Intraday BUY SELL Signals
DICE
Price
$25.88
Change
-$0.13 (-0.50%)
Updated
Sep 22, 04:14 PM (EDT)
Net Assets
1.94M
Intraday BUY SELL Signals
Interact to see
Advertisement

CLDX vs DICE

CLDX vs DICE Comparison Chart in %
loading
View a ticker or compare two or three
VS
CLDX vs. DICE commentary
Sep 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and DICE is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDX
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
COMPARISON
Comparison
Sep 23, 2026
Stock price -- (CLDX: $37.89)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green while .

  • CLDX’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 4 TA indicator(s) are bullish.

  • CLDX’s TA Score: 4 bullish, 6 bearish.

Price Growth

CLDX (@Biotechnology) experienced а -3.29% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +27.63%. For the same industry, the average monthly price growth was -6.27%, and the average quarterly price growth was +7.77%.

Reported Earning Dates

CLDX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+27.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CLDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RINT32.690.35
+1.09%
International Developed Equity ETF (RINT)
QBKV27.240.10
+0.39%
AllianzIM U.S. Small Cap Buffer5 ETF (QBKV)
CVAR30.71N/A
N/A
Cultivar ETF (CVAR)
SPHD49.85-0.38
-0.76%
Invesco S&P 500 High Dividend Low Volatility ETF (SPHD)
UMI59.61-0.66
-1.09%
USCF Midstream Energy Income Fund ETF (UMI)

DICE and

Correlation & Price change

A.I.dvisor tells us that DICE and IPSC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DICE and IPSC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DICE
1D Price
Change %
DICE100%
+2.39%
IPSC - DICE
32%
Poorly correlated
-0.54%
CYTK - DICE
32%
Poorly correlated
-1.77%
CLDX - DICE
31%
Poorly correlated
-0.92%
VKTX - DICE
30%
Poorly correlated
+3.86%
ORMP - DICE
30%
Poorly correlated
-0.84%
More